Clinical Trials Directory

Trials / Completed

CompletedNCT02502682

Chlorhexidine Bathing Effect on Clostridium Difficile Rates

Effect of Daily Chlorhexidine Bathing on Clostridium Difficile Rates on the General Medical Floor in Patients Receiving Antibiotics

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
167 (actual)
Sponsor
Jared Brooks · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Clostridium difficile (C. diff.) infections, whether nosocomial or community borne, may present with profound diarrhea, especially in those patients receiving antibiotics. Based on a preliminary review of hospital data, the investigators have found that these symptomatic c. diff infections occur with a relatively high incidence at Delnor Hospital. Notwithstanding their high mortality, one recent study attributes a near quadrupling of hospitalization costs to c. diff infections. Chlorhexidine baths have been shown in multiple randomized trials to help reduce the incidence of highly virulent pathogens and hospital acquired infections. Further, several studies show a favorable effect of reducing the incidence of c. diff infections by using Chlorhexidine baths on ICU patients. Far fewer studies, however, have focused on the effects of these baths on general medical/surgical wards. This investigation seeks to study the effect of the daily use of 2% Chlorhexidine gluconate wipes in patients on the general medical/surgical wards who are exposed to antibiotics for a suspected or confirmed infection.

Conditions

Interventions

TypeNameDescription
DRUGSage 2% Chlorhexidine Gluconate Cloth Patient Preoperative Skin PreparationDaily bathing.

Timeline

Start date
2015-07-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2015-07-20
Last updated
2016-07-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02502682. Inclusion in this directory is not an endorsement.